Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry Developments

All Articles
:

BMI View: The heterogenous nature of the healthcare markets in the Middle East and Africa (MEA) makes the need for the prioritisation of markets according to potential risks and rewards... 2012-02-15


United Arab Emirates

BMI View: An integrated health information system (HIS) increases hospital productivity, reduces administration costs and medical errors, increases accountability and shortens waiting... 2012-02-10


Jordan

BMI Core View: Political stability, a cost-effective healthcare system and an established tourism sector are the fundamental prerequisites for developing a medical tourism industry.... 2012-02-09


Lebanon

BMI View: Continued improvement to Lebanon's intellectual property (IP) and pharmaceutical regulatory environment reinforces BMI's view that the country will begin to attract investment... 2012-02-08


BMI View: Though estimates of the burden of malaria differ between the World Health Organization (WHO) and the new research by Murray et al, 2012, the new data changes very little.... 2012-02-07


United Arab Emirates

BMI View: Diabetes and cardiovascular diseases are the Middle East and North Africa (MENA)'s biggest epidemiological challenge. The underlying cause of these diseases is obesity. The... 2012-02-06


BMI View: GE Healthcare has capitalised on the demand for medical devices and healthcare service solutions in the Middle East. With the wave of new hospitals being built across the... 2012-02-03


United Arab Emirates

BMI View: Attempts in the Gulf region to take a more preventative stance against public health issues is commendable, but changing attitudes and weaning the population of their tobacco... 2012-02-01


BMI View: The very survival of The Global Fund to Fight AIDS, Tuberculosis and Malaria was in doubt for the past year due to allegations of monetary misappropriation and a slowdown... 2012-01-31


Mozambique

BMI View: Mozambique's pharmaceutical market is characterised by a poor regulatory framework, an abundance of counterfeit medicines, low levels of government spending, a very small... 2012-01-27

51 to 60 of 1094 results
<< | < | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | > | >>
Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries